Act Co Ltd (138360) - Net Assets
Based on the latest financial reports, Act Co Ltd (138360) has net assets worth ₩87.24 Billion KRW (≈ $59.12 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩131.21 Billion ≈ $88.92 Million USD) and total liabilities (₩43.97 Billion ≈ $29.80 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see 138360 market cap.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩87.24 Billion |
| % of Total Assets | 66.49% |
| Annual Growth Rate | 7.34% |
| 5-Year Change | 17.97% |
| 10-Year Change | N/A |
| Growth Volatility | 46.97 |
Act Co Ltd - Net Assets Trend (2014–2025)
This chart illustrates how Act Co Ltd's net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for Act Co Ltd (2014–2025)
The table below shows the annual net assets of Act Co Ltd from 2014 to 2025. See 138360 net asset quality score to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩85.42 Billion ≈ $57.88 Million |
+63.20% |
| 2024-12-31 | ₩52.34 Billion ≈ $35.47 Million |
+39.79% |
| 2023-12-31 | ₩37.44 Billion ≈ $25.37 Million |
-4.99% |
| 2022-12-31 | ₩39.40 Billion ≈ $26.70 Million |
-45.58% |
| 2018-12-31 | ₩72.40 Billion ≈ $49.07 Million |
+112.69% |
| 2017-12-31 | ₩34.04 Billion ≈ $23.07 Million |
-10.80% |
| 2016-12-31 | ₩38.16 Billion ≈ $25.86 Million |
-5.44% |
| 2015-12-31 | ₩40.36 Billion ≈ $27.35 Million |
+2.98% |
| 2014-12-31 | ₩39.19 Billion ≈ $26.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Act Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 42477.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩29.73 Billion | 34.80% |
| Other Components | ₩55.69 Billion | 65.20% |
| Total Equity | ₩85.42 Billion | 100.00% |
Act Co Ltd Competitors by Market Cap
The table below lists competitors of Act Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
|
$76.85 Million |
|
Vow ASA
OL:VOW
|
$76.86 Million |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
$76.89 Million |
|
Taeyang Metal Industrial Co Ltd
KO:004105
|
$76.89 Million |
|
Gain Therapeutics Inc
NASDAQ:GANX
|
$76.78 Million |
|
Hancock & Gore Ltd
AU:HNG
|
$76.76 Million |
|
KPS Corporation
KQ:256940
|
$76.74 Million |
|
Kelly Services B Inc
NASDAQ:KELYB
|
$76.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Act Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 52,336,459,740 to 85,415,672,220, a change of 33,079,212,480 (63.2%).
- Net income of 6,861,739,910 contributed positively to equity growth.
- New share issuances of 14,971,489,800 increased equity.
- Other factors increased equity by 11,245,982,770.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩6.86 Billion | +8.03% |
| Share Issuances | ₩14.97 Billion | +17.53% |
| Other Changes | ₩11.25 Billion | +13.17% |
| Total Change | ₩- | 63.20% |
Book Value vs Market Value Analysis
This analysis compares Act Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.56x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ₩1139.49 | ₩1731.00 | x |
| 2023-12-31 | ₩1082.69 | ₩1731.00 | x |
| 2024-12-31 | ₩1083.19 | ₩1731.00 | x |
| 2025-12-31 | ₩1109.86 | ₩1731.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Act Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.03%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.36%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.27x
- Recent ROE (8.03%) is above the historical average (-1.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 11.17% | 23.57% | 0.41x | 1.15x | ₩456.22 Million |
| 2015 | 4.60% | 9.18% | 0.45x | 1.12x | ₩-2.16 Billion |
| 2016 | -4.50% | -6.80% | 0.54x | 1.22x | ₩-5.49 Billion |
| 2017 | -14.71% | -20.25% | 0.47x | 1.53x | ₩-8.18 Billion |
| 2018 | -5.26% | -19.72% | 0.20x | 1.33x | ₩-11.05 Billion |
| 2022 | -15.38% | -40.54% | 0.29x | 1.32x | ₩-10.00 Billion |
| 2023 | -5.04% | -18.35% | 0.20x | 1.41x | ₩-5.63 Billion |
| 2024 | 8.83% | 21.50% | 0.30x | 1.35x | ₩-610.34 Million |
| 2025 | 8.03% | 29.36% | 0.21x | 1.27x | ₩-1.68 Billion |
Industry Comparison
This section compares Act Co Ltd's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $703,921,184,272
- Average return on equity (ROE) among peers: 3.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Act Co Ltd (138360) | ₩87.24 Billion | 11.17% | 0.50x | $76.78 Million |
| Rifa Ind (000760) | $207.07 Billion | -0.30% | 0.30x | $26.72 Million |
| Kumyang (001570) | $45.55 Billion | 1.44% | 2.23x | $428.33 Million |
| Sh E & Chemical Co. Ltd. (002360) | $69.60 Billion | 6.93% | 0.59x | $11.14 Million |
| KCC Corporation (002380) | $1.84 Trillion | 6.97% | 0.75x | $2.34 Billion |
| Miwon Commerci (002840) | $76.90 Billion | 13.31% | 0.59x | $421.27 Million |
| Taekwang Ind (003240) | $1.35 Trillion | 3.15% | 0.23x | $512.75 Million |
| Lotte Fine Chemical Co Ltd (004000) | $1.20 Trillion | 5.12% | 0.54x | $814.70 Million |
| Dongjin Semichem Co. Ltd (005290) | $133.60 Billion | 11.30% | 2.71x | $1.49 Billion |
| Isu Chemical Co Ltd (005950) | $221.73 Billion | -21.39% | 3.32x | $206.51 Million |
| Korea Petro Chemical Ind (006650) | $1.89 Trillion | 6.72% | 0.12x | $374.60 Million |
About Act Co Ltd
NRobotics Co.,Ltd. manufactures and trades domestic meat processing equipment in South Korea and internationally. The company provides meat preprocessing equipment, comprising flakers, meat grinders, vacuum and chiller mixers, defrosting and vacuum tumblers, and injectors; ham sausage processing machines, consisting of smokehouse, intensive and alcohol chillers, sausage peelers, drum cutters, and… Read more